Cell isolation is the process of isolating specific cells from the given samples. It is a powerful tool in biological research that enables an individual cell type to be isolated from a heterogeneous cell population without contamination from another cell type. This process is widely used for biomolecule isolation for the production of vaccines, drugs, antibodies, enzymes, proteins, and other biotechnology products.

Expected Revenue Growth:

The Cell Isolation Procedure Market is projected to grow from USD 5.9 billion in 2019 to USD 13.0 billion by 2024, at a CAGR of 17.2% during the forecast period.

Major Growth Boosters:

Growth in the cell isolation market is mainly driven by the growing government funding for cell-based research, the increasing number of patients who have cancer and infectious diseases, technological advancements, and the ever-increasing focus on personalized medicine.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479

Industry Segmentations:

Biotechnology & biopharmaceutical companies to hold the largest share of the market during the forecast period.

Based on end users, the cell isolation market is segmented into research laboratories & institutes, hospitals & diagnostic laboratories, biotechnology & biopharmaceutical companies, and other end users. The biotechnology & biopharmaceutical companies segment accounted for the largest market share in 2018. The large share of this segment is attributed to the widespread adoption of advanced instruments in cell-based experiments and cancer research in biotechnology & biopharmaceutical companies and the increasing number of R&D facilities globally.

The centrifugation-based cell isolation technique is expected to hold the largest share of the market during the forecast period.

On the basis of technique, the Cell Isolation Procedure Market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. The centrifugation-based cell isolation segment is expected to account for the largest market share in 2018. This technique is used on a large scale by biotech and biopharmaceutical companies and its cost-effectiveness in both small-scale and large-scale operations is a major reason its dominant share.

Cell isolation consumables dominated the market in 2018.

On the basis of type, the cell isolation market is segmented into consumables and instruments. In 2018, the consumables segment accounted for a larger share of the cell isolation market. The dominant share of this segment can be attributed to the increasing investments by companies to develop technologically advanced products and the repetitive use of consumables.

North America held the largest share of the market in 2018.

The cell isolation market is segmented into four major geographic segments North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America commanded the largest share of the cell isolation market, followed by Europe. The large share of the North American market is attributed to technological advancements, growth in the biotechnology and pharmaceutical industries, increasing prevalence of chronic and infectious diseases, and higher investments in cell-based research in the region.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479

Global Market Players:

Prominent players in the Cell Isolation Procedure Market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KgaA (Germany), Miltenyi Biotec (Germany), pluriSelect (Germany), STEMCELL Technologies Inc. (Canada), Terumo BCT (US), Thermo Fisher Scientific (US), and Bio-Rad Laboratories Inc. (US).

The key strategies followed by most companies in the cell isolation market are product launches, expansions, agreements, and acquisitions to achieve growth in the cell isolation market. The product launches accounted for the largest share of the overall growth strategies adopted from 2015 to 2018.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]